World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
9226
World Ranking
3998
National Ranking
156

Overview

Harry Dolstra is affiliated with Radboud University in the Netherlands and has made contributions in the fields of medicine, immunology, and microbiology. Their research primarily spans immunology, oncology, hematology, physiology, and molecular biology. The work frequently addresses topics such as CAR-T cell therapy research, immune cell function and interaction, T-cell and B-cell immunology, immunotherapy and immune responses, hematopoietic stem cell transplantation, reproductive system and pregnancy, and immune cells in cancer.

The research output includes numerous publications, with a notable presence in several scientific journals. The most frequent publication venues for Dolstra's work include:

  • Bone Marrow Transplantation
  • Cytotherapy
  • Cancer Immunology Immunotherapy
  • Leukemia Research
  • OncoImmunology

Dolstra's recent papers cover topics related to hematopoietic cell transplantation, cellular therapies, and immune cell cytotoxicity. Selected recent publications include:

  • "Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years" (2021), Bone Marrow Transplantation
  • "Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022" (2022), Bone Marrow Transplantation
  • "Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity" (2021), Nature Communications
  • "The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy" (2020), Bone Marrow Transplantation
  • "The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus" (2020), Bone Marrow Transplantation

Collaboration is a significant part of Dolstra's work, with several frequent co-authors, including:

  • Willemijn Hobo
  • Joop H. Jansen
  • Paul K.J.D. de Jonge
  • Nicolaas Schaap
  • Anniek B. van der Waart

Best Publications

  • Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

    Jakob R. Passweg;Helen Baldomero;Christian Chabannon;Grzegorz W. Basak

  • Induction of myelodysplasia by myeloid-derived suppressor cells.

    Xianghong Chen;Erika A. Eksioglu;Junmin Zhou;Ling Zhang

  • A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia

    H. Dolstra;H. Fredrix;F.M.H.M. Maas;P.G. Coulie

  • Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti–PD-L1 Antibodies

    Sandra Heskamp;Willemijn Hobo;Janneke D.M. Molkenboer-Kuenen;Daniel Olive

  • Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.

    Jan Spanholtz;Frank Preijers;Marleen Tordoir;Carel Trilsbeek

  • Comprehensive Phenotyping of T Cells Using Flow Cytometry.

    Charlotte M. Mousset;Willemijn Hobo;Rob Woestenenk;Frank Preijers

  • Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients

    Harry Dolstra;Mieke W.H. Roeven;Jan Spanholtz;Basav N. Hangalapura

  • Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity.

    Bettina Weigelin;Annemieke Th den Boer;Esther Wagena;Kelly Broen

  • PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

    Wieger J. Norde;Frans Maas;Willemijn Hobo;Alan Korman

  • The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.

    Per Ljungman;Per Ljungman;Malgorzata Mikulska;Rafael de la Camara;Grzegorz W Basak

  • High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy

    Jan Spanholtz;Marleen Tordoir;Diana Eissens;Frank Preijers

  • siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen–specific CD8+ T cells

    Willemijn Hobo;Frans Maas;Niken Adisty;Theo de Witte

  • The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus.

    Jakob R. Passweg;Helen Baldomero;Christian Chabannon;Grzegorz W. Basak

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia

    Björn de Rijke;Agnes van Horssen-Zoetbrood;Jeffrey M. Beekman;Britt Otterud

  • Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

    Florian Wimmers;Florian Wimmers;Nikita Subedi;Nicole van Buuringen;Daan Heister

  • Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy

    Anniek B. van der Waart;Noortje M. P. van de Weem;Frans Maas;Cynthia S. M. Kramer

  • Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.

    H. Dolstra;H. Fredrix;F.W.M.B. Preijers;E. Goulmy

  • Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms.

    F.M.H.M. Maas;N.P.M. Schaap;S.M.H. Kolen;A. Zoetbrood

  • Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

    Willemijn Hobo;Tatiana I. Novobrantseva;Hanny Fredrix;Jamie Wong

  • Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice

    Jeannette Cany;Anniek B van der Waart;Marleen Tordoir;Gerben M. Franssen

Frequent Co-Authors

Joop H. Jansen
Joop H. Jansen Radboud University
Theo de Witte
Theo de Witte Radboud University
Carl G. Figdor
Carl G. Figdor Radboud University
J.H. Frederik Falkenburg
J.H. Frederik Falkenburg Leiden University Medical Center
Leon F.A.G. Massuger
Leon F.A.G. Massuger Radboud University
Otto C. Boerman
Otto C. Boerman Radboud University
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
Peter Friedl
Peter Friedl Radboud University Medical Center
Daniel Olive
Daniel Olive Aix-Marseille University
Arjan C. Lankester
Arjan C. Lankester Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding career options in healthcare often involves exploring related nursing programs. Those seeking an entry point into healthcare might consider the which lpn programs are easiest to get into, as Licensed Practical Nurse roles offer quick transitions into patient care with manageable program requirements.

Advancing beyond LPN, many pursue family nurse practitioner roles. Identifying the easiest fnp program can help streamline the process, enabling students to gain advanced practice licenses more efficiently while preparing for diverse clinical settings.

For those interested in mental health, psychiatric nursing is a fast-growing field where programs offering strong clinical placements are critical. Exploring the best psychiatric mental health nurse practitioner programs online ensures practical experience in real-world settings, a key to successful licensure and career readiness.

Cost is also a significant factor in choosing a program. Many students benefit from researching affordable pmhnp programs, which minimize financial barriers while maintaining quality education, supporting a sustainable path towards specialized Immunology-related healthcare roles.

Best Scientists Citing Harry Dolstra

Trending Scientists